… , and chronic thromboembolic pulmonary hypertension (CTEPH). … an initial dose of rivaroxaban,
four were directly treated with the … opportunity for multidisciplinary quality improvement to …

… after cessation of anticoagulant therapy. These adverse events include recurrent venous
thromboembolism, chronic thromboembolic pulmonary hypertension, … and decreased quality of …

… is associated with a very poor prognosis and high risk of … outpatient clinic after an initial
anticoagulant treatment period of … patients with CTEPH have a substantially reduced quality of life …

… to the haemodynamics and quality of life [5–7]. Therefore, … matching the initial 1699 patients
with pulmonary embolism with … 3 months of effective anticoagulation therapy and radiological …

… /or decreased quality of life following an acute PE diagnosis), … received 3 months of
anticoagulation therapy, mild COPD … signs of CTEPH on initial CTPA scans with confirmed acute …

… pulmonary emboli cause chronic obstruction of the … with CTEPH are treated with DOAC
from the time of their initial … -term survival, severe functional limitations and poor quality of life […

… initial bolus dose followed by a continuous infusion. A shift to LMWH or direct oral anticoagulant
(DOAC) was allowed early after … Early recognition of underlying CTEPH in acute PE is of …

… chronic thromboembolic pulmonary hypertension (CTEPH), … that the risks and benefits of
indefinite anticoagulant therapy are … quality of life and is costly, its prevention and treatment are …

… , 0 (indicates low risk with a risk of 1.5% recurrent venous thromboembolism and a 1.1% …
regarding the diagnosis and treatment of acute pulmonary thromboembolism in adults. …

… of stay, quality of life, and possibly mortality risk reduction. Long-… therapy with tenecteplase
plus heparin anticoagulation … The incidence of CTEPH after an initial PE ranges from 1 to 4% …